Flexion Therapeutics, Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2018. The company’s revenue for the fourth-quarter of 2018 is estimated to be $9.5 million, an increase of 36% over the previous quarter. The company’s total revenue for the full-year 2018 is estimated to be $22.5 million.